Retrospective Analysis for Patients With Metabolic Syndrome

Retrospective Analysis of Outpatient Intervention Effects in Patients With Metabolic Syndrome

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06182618

Enrollment

400

Registered

2023-12-27

Start date

2023-06-01

Completion date

2024-01-01

Last updated

2023-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Brief summary

The incidence of metabolic syndrome and related diseases is gradually increasing, and diet and medication are currently common outpatient treatment methods. This study retrospectively analyzes the clinical data of patients with metabolic syndrome and related diseases who have visited our outpatient department in the past 10 years, compares the therapeutic effects of different treatment methods on their blood glucose, blood lipids, blood pressure, uric acid, and body composition, and provides evidence support for clinical treatment.

Interventions

OTHERdietary, semaglutide or/and metformin

patients were prescribed dietary and pharmaceuticals for weight loss

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

• individuals who had at least a 2 follow up visits with a BMI of 24 or more with the pri-mary goal of losing weight.

Exclusion criteria

* patients did not follow-up on a monthly basis; * patients followed-up less than 1 times within 3 months; * patients having incomplete data; * patients changing their interventions during fol-low-ups

Design outcomes

Primary

Measure	Time frame	Description
weight	0month/1month/2months/3 months	Weight was measured through multi-frequency bioelectrical impedance analysis InBody 720 (Bio Space Co., Seoul, Korea) at various time points

Secondary

Measure	Time frame	Description
visceral fat area(VFA)	0month/1month/2months/3 months	VFA was measured through multi-frequency bioelectrical impedance analysis InBody 720 (Bio Space Co., Seoul, Korea) at various time points
skeletal muscle mass(SMM)	0month/1month/2months/3 months	SMM was measured through multi-frequency bioelectrical impedance analysis InBody 720 (Bio Space Co., Seoul, Korea) at various time points

Countries

China

Contacts

Primary Contactleilei wang

2513118@zju.edu.cn0571-87783851

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026